PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast to between Euro 22 and 26 million
Public disclosure of inside information according to article 17 MAR
Gräfelfing/München (pta026/04.12.2017/15:30) - The Hönle Group increases its profit forecast (EBIT) for the financial year 2017/2018 from between Eur16 and 18 million to between Eur22 and 26 million. This considerable increase in profit is due to an anticipated strong development of the business, particularly in the segment Adhesives. The number of applications for adhesives in the manufacture of smartphones has been considerably expanded. As a consequence, Hönle anticipates that its business with adhesives in the field of consumer electronics will develop highly positively. In addition, increasing sales and profit in the segments Equipment & Systems as well as Glass & Lamps are assumed. Sales of between Eur105 and 115 million originally anticipated have therefore been adjusted to between Eur115 and 125 million.
Provisional figures for the past financial year will be published on 15 December 2017. The management board continues to anticipate sales of between Eur95 and 105 million and an operating profit (EBIT) of between Eur14 and 16 million for the Hönle Group in the financial year 2016/2017.
Dr. Hönle AG is a listed technology company with head office in Gräfelfing, near Munich. With a staff level of more than 500 employees, the Hönle Group develops innovative solutions for different industrial production processes. The equipment is used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The company's business activities also include the development and sale of industrial adhesives and sealings. In addition, the group manufactures UV lamps that are used in water sterilisation and for other applications, and produces tubing and semi-finished goods made of quartz glass that are used by various branches of industry. The Hönle Group is represented worldwide in 28 countries by own companies and sales partners.
emitter: Dr. Hönle AG
address: Lochhamer Schlag 1, 82166 Gräfelfing/München
contact person: Peter Weinert
phone: +49 89 85608-173
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate